Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate CancerWilliam Morris, Nevin Murray, Scott Tyldesley et al.|International Journal of Radiation Oncology*Biology*Physics|2016Cited by 736
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate CancerNevin Murray, Scott Tyldesley, William Morris et al.|International Journal of Radiation Oncology*Biology*Physics|2017Cited by 319
Testosterone recovery following prolonged adjuvant androgen ablation for prostate carcinomaTom Pickles, Graeme Duncan, Mira Keyes et al.|Cancer|2002Cited by 107
Watchful waiting or watchful progression?Duncan B. McLaren, Tom Pickles, Michael McKenzie et al.|Cancer|1998Cited by 98
ASCENDE-RT*: A multicenter, randomized trial of dose-escalated external beam radiation therapy (EBRT-B) versus low-dose-rate brachytherapy (LDR-B) for men with unfavorable-risk localized prostate cancer.William Morris, Jeremy Hamm, Scott Tyldesley et al.|Journal of Clinical Oncology|2015Cited by 96